GLP1R and type 2 diabetes mellitus: GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP4) inhibitors, which prevent the degradation of endogenous GLP-1, are widely used in the treatment of type 2 diabetes [28,29,30].